BAYRY News and Press, Bayer AG ADR From 06/21/22

Exelixis (NASDAQ:EXEL) said it began a phase 3 trial of XL092 in combination with Roche's (OTCQX:RHHBY) (OTCQX:RHHBF) Tecentriq (atezolizumab) versus Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) Stivarga (regorafenib) in patients with metastatic colorectal cancer which is not microsatellite insta...

The war in Ukraine is no longer the major market mover as record inflation has now taken that spot. Markets are very nervous and record inflation readings paired with an aggressive Fed and negative consumer sentiment are starting to hammer stocks and hopefully lead to a prolonged bear...

The U.S. Supreme Court has rejected Bayer's (OTCPK:BAYRY) appeal to dismiss thousands of lawsuits claiming that its Roundup weedkiller causes cancer The justices left in place a lower court decision that upheld $25M in damages awarded to a California resident who blamed his cancer on the use ...

The Environmental Protection Agency was ordered by the Ninth U.S. Circuit Court of Appeals on Friday to reassess whether glyphosate, the active ingredient in Bayer's (OTCPK:BAYRY) popular Roundup weedkiller, poses unreasonable risks to humans and the environment, Reuters reports. The court ag...

TherapeuticsMD’s $177 million buyout deal with EW Healthcare largely undervalues the biotech. TherapeuticsMD is close to stimulating the commercialization of Annovera which may increase its value as a standalone company in the long run. Shareholders were informed of a 50:1 ...

Dr. Reddy's Laboratories  (NYSE:RDY) launched its sorafenib tablets, a generic of Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) kidney/liver/thyroid cancer drug Nexavar (sorafenib), in the U.S. following the approval by the U.S. Food and Drug Administration (FDA). Dr. Reddy's sorafenib tablet...

The U.S. Supreme Court took no action on Monday in Bayer's (OTCPK:BAYRY) effort to dismiss legal claims by customers who contend the company's Roundup weedkiller causes cancer, apparently meaning it will not issue a decision until next week. Bayer has asked the Court to take up its appeal of ...

Investors should pay close attention to Bayer (OTCPK:BAYRY) as soon as Monday as the Supreme Court is set to decide if it will take up its case over a $25 million verdict concerning Roundup weedkiller litigation. The Supreme Court is expected Monday to say if it will hear the Bayer (OTCPK:BAY...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Bayer (OTCPK:BAYRY) said on Friday that a Missouri court ruled in its favor in a trial regarding claims that its Roundup weedkiller causes cancer, which would mark a third consecutive court victory for the company in the U.S. Previously, three U.S. juries had found in favor of plaintiffs who ...